Current status of body MR imaging: Fast MR imaging and diffusion-weighted imaging

被引：21

作者：

Koyama T. ^{[1
]}

Tamai K. ^{[2
]}

Togashi K. ^{[2
]}

机构：

[1] Department of Radiology, Kyoto University Hospital, Sakyo-ku, Kyoto 606-8507

[2] Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto

来源：

International Journal of Clinical Oncology | 2006年 / 11卷 / 4期

关键词：

Body MR imaging; Diffusion weighted MR imaging; Fast MR imaging; Malignancy;

D O I：

10.1007/s10147-006-0605-2

中图分类号：

学科分类号：

摘要：

The recent technical advances in fast MR imaging have greatly enhanced the clinical value of MR imaging of the body. Advances in T1-weighted images have enabled the acquisition of dynamic contrast-enhanced MR imaging, which is currently central to hepatic MR imaging for detection and characterization of liver tumors and is also useful for the evaluation of myometrial invasion in uterine cor-pus cancer. Advances in rapid T 2-weighted MR imaging with single-shot fast spin-echo images have enabled MR cholangiopancreatography and MR urography. Application of respiratory triggering can also provide T2-weighted images of high quality. Cine MR imaging utilizing ultrafast MR sequences enables the assessment of the respiratory motion of the lung for evaluating thoracic wall invasion by tumors. Diffusion-weighted images can provide excellent tissue contrast based on molecular diffusion and have the potential to demonstrate malignant tumors. Quantitative measurement of apparent diffusion coefficient values may also be valuable in distinguishing malignancies from benign lesions. © The Japan Society of Clinical Oncology 2006.

引用

页码：278 / 285

页数：7

共 43 条

[1]

Carlson J., Crooks L., Ortendahl D., Signal-to-noise ratio and section thickness in two-dimensional versus three-dimensional Fourier transform MR imaging, Radiology, 166, pp. 266-270, (1988)

[2]

Rofsky N.M., Lee V.S., Laub G., Abdominal MR imaging with a volumetric interpolated breath-hold examination, Radiology, 212, pp. 876-884, (1999)

[3]

Hawighorst H., Knapstein P.G., Weikel W., Cervical carcinoma: Comparison of standard and pharmacokinetic MR imaging, Radiology, 201, pp. 531-539, (1996)

[4]

Mayr N.A., Yuh W.T., Magnotta V.A., Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: A new noninvasive predictive assay, Int J Radiat Oncol Biol Phys, 36, pp. 623-633, (1996)

[5]

Yang J.C., Haworth L., Sherry R.M., A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer, N Engl J Med, 349, pp. 427-434, (2003)

[6]

Morgan B., Thomas A.L., Drevs J., Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: Results from two phase I studies, J Clin Oncol, 21, pp. 3955-3964, (2003)

[7]

Padhani A.R., MRI for assessing antivascular cancer treatments, Br J Radiol, 76, (2003)

[8]

Padhani A.R., Leach M.O., Antivascular cancer treatments: Functional assessments by dynamic contrast-enhanced magnetic resonance imaging, Abdom Imaging, 30, pp. 324-341, (2005)

[9]

Hennig J., Friedburg H., Clinical applications and methodological developments of the RARE technique, Magn Reson Imaging, 6, pp. 391-395, (1988)

[10]

Fulcher A.S., Turner M.A., Capps G.W., Half-Fourier RARE MR cholangiopancreatography: Experience in 300 subjects, Radiology, 207, pp. 21-32, (1998)

← 1 2 3 4 5 →